| Review of the MitraClip clinical evidence. | |
| | |
MedLine Citation:
|
PMID: 22322576 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
MitraClip system is the only catheter-based device for percutanoeus mitral valve repair available for clinical use, after receipt of the CE Mark in 2008, while it is currently under review for FDA approval in the US. To date, over 3500 MitraClip implants have been performed worldwide, mainly in high risk surgical patients. The aim of this review is to review all the current evidences of the MitraClip therapy in an aim to define its clinical role in the treatment of mitral regurgitation (MR). |
| | |
Authors:
|
F Maisano; M Taramasso; M Cioni; N Buzzatti; P Denti; A Colombo; O Alfieri |
Related Documents
:
|
7851206 - Familial adenomatous polyposis and inflammatory bowel disease associated in two kindreds. 6439406 - Familial periodic ataxia responsive to acetazolamide. 18654886 - A rare thalassemic syndrome caused by interaction of hb adana [alpha59(e8)gly-->asp] wi... 6389316 - Pericentric inversions. problems and significance for clinical genetics. 2948546 - Septic arthritis of the temporo-mandibular joint--a problematic diagnosis. 9399776 - Acute pancreatitis after long-term 5-aminosalicylic acid therapy. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Minerva cardioangiologica Volume: 60 ISSN: 0026-4725 ISO Abbreviation: Minerva Cardioangiol Publication Date: 2012 Feb |
Date Detail:
|
Created Date: 2012-02-10 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0400725 Medline TA: Minerva Cardioangiol Country: Italy |
Other Details:
|
Languages: eng Pagination: 85-94 Citation Subset: IM |
Affiliation:
|
Cardiothoracic Department, San Raffaele Hospital, Milan, Italy - francesco.maisano@hsr.it. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: My rules of a perfect SAPIEN™ transcatheter aortic valve implantation.
Next Document: Glycoprotein IIb/IIIa inhibitors and bivalirudin in patients undergoing percutaneous coronary interv...